Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1920 ARTÍCULOS , VIENDO DEL 181 AL 195

Brain Banking in Dementia Studies

Isik AT, Kaya D, Gokden M.

Methods Mol Biol. 2024;2785:287-295. doi: 10.1007/978-1-0716-3774-6_17.

Lactate/Hydroxycarboxylic Acid Receptor 1 in Alzheimer's Disease: Mechanisms and Therapeutic Implications-Exercise Perspective

Meng X, Wu W, Tang Y, Peng M, Yang J, Yuan S, Hu Z, Liu W.

Mol Neurobiol. 2024 Oct;61(10):7717-7731. doi: 10.1007/s12035-024-04067-x. Epub 2024 Mar 1.

Cognitive Effect of Transcranial Direct Current Stimulation on Left Dorsolateral Prefrontal Cortex in Mild Alzheimer's Disease: A Randomized, Double-Blind, Cross-Over Small-Scale Exploratory Study

Wang CS, Chen PS, Tsai TY, Hou NT, Tang CH, Chen PL, Huang YC, Cheng KS.

J Alzheimers Dis. 2024;98(2):563-577. doi: 10.3233/JAD-240002.

Aβ-binding with alcohol dehydrogenase drives Alzheimer's disease pathogenesis: A review

Ye Z, Liu Y, Jin X, Wu Y, Zhao H, Gao T, Deng Q, Cheng J, Lin J, Tong Z.

Int J Biol Macromol. 2024 Apr;264(Pt 2):130580. doi: 10.1016/j.ijbiomac.2024.130580. Epub 2024 Mar 1.

Generation of an induced pluripotent stem cell line (PNUYHi002-A) from a patient with Alzheimer's disease carrying PRNP M232R variant

Kim MK, Kim Y, Lee N, Moon HJ, Lee JH, Kim EJ, Kim YJ, Kim JH, Jung NY.

Stem Cell Res. 2024 Apr;76:103361. doi: 10.1016/j.scr.2024.103361. Epub 2024 Feb 28.

Safety and efficacy of acetylcholinesterase inhibitors for Alzheimer's disease: A systematic review and meta-analysis

Gao Y, Liu Y, Li Y.

Adv Clin Exp Med. 2024 Nov;33(11):1179-1187. doi: 10.17219/acem/176051.

Unraveling Amentoflavone's Therapeutic Potential in Alzheimer's Disease: A Preclinical Assessment

Singh S, Agrawal N, Goyal A.

Comb Chem High Throughput Screen. 2024;27(13):1851-1860. doi: 10.2174/0113862073301291240229102657.

Insulin Delivery to the Brain via the Nasal Route: Unraveling the Potential for Alzheimer's Disease Therapy

Wong CYJ, Baldelli A, Hoyos CM, Tietz O, Ong HX, Traini D.

Drug Deliv Transl Res. 2024 Jul;14(7):1776-1793. doi: 10.1007/s13346-024-01558-1. Epub 2024 Mar 5.

Phytochemicals targeting Alzheimer's disease via the AMP-activated protein kinase pathway, effects, and mechanisms of action

Zhao Z, Yan J, Huang L, Yang X.

Biomed Pharmacother. 2024 Apr;173:116373. doi: 10.1016/j.biopha.2024.116373. Epub 2024 Mar 4.

Protein-protein interaction network analysis for the identification of novel multi-target inhibitors and target miRNAs against Alzheimer's disease

Kumar V, Roy K.

Adv Protein Chem Struct Biol. 2024;139:405-467. doi: 10.1016/bs.apcsb.2023.11.005. Epub 2024 Feb 15.

Recent advances in the total synthesis of galantamine, a natural medicine for Alzheimer's disease

Cheng B, Wang Q, An Y, Chen F.

Nat Prod Rep. 2024 Jul 17;41(7):1060-1090. doi: 10.1039/d4np00001c.

Molecular hybridization: a powerful tool for multitarget drug discovery

de Sena Murteira Pinheiro P, Franco LS, Montagnoli TL, Fraga CAM.

Expert Opin Drug Discov. 2024 Apr;19(4):451-470. doi: 10.1080/17460441.2024.2322990. Epub 2024 Mar 8.

Nanotechnology-based delivery of therapeutics through the intranasal pathway and the blood-brain barrier for Alzheimer's disease treatment

Boyetey MB, Choi Y, Lee HY, Choi J.

Biomater Sci. 2024 Apr 16;12(8):2007-2018. doi: 10.1039/d3bm02003g.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias